Skip to main content
OpenTrials
Enrolling by Invitation

NCT Number: NCT04246970

Prehabilitation and Posttransplant Training Program in Liver Transplantation

PreLiveR-T consists of a prospective randomized clinical trial conducted in an adult population that is a candidate for liver transplantation (LT) at the Hospital La Fe Valencia (Spain). The study is structured in three phases: I) Prehabilitation (2 months before LT); II) Training, divided in two successive periods: Supervised training (months 3-6 after LT) and Unsupervised training (6-12 months after LT); III) Long-term follow-up (2 years after LT).

Primary outcomes are related to post-surgery evolution (morbidity and mortality, hospitalization length, etc.). As a secondary outcomes are collected those related to: functional capacity, muscle strength and quality of life.

Enrolling by Invitation

Interested in participating?

Request Info

Key information

Conditions

Liver Transplant; Complications Adenocarcinoma Carcinoma Carcinoma, Hepatocellular Cirrhosis, Liver Digestive System Diseases Digestive System Neoplasms Fibrosis Hepatic Carcinoma Liver Cirrhosis Liver Diseases Liver Neoplasms Neoplasms Neoplasms by Histologic Type Neoplasms by Site Neoplasms, Glandular and Epithelial Pathologic Processes Pathological Conditions, Signs and Symptoms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Hospital Universitari i Politècnic La Fe

Valencia, 46026, Spain

About this study

The main objective is to study the post-surgical impact (post-S) of a Prehabilitation program on candidates for liver transplantation (LT), as well as to study the effects of posttransplant training on the clinical and functional evolution of the recipients. Also this project pretends to assess the influence of functional capacity (FC) improvement on the short and long term post-S evolution of the LT candidates. This is a prospective randomized clinical trial in which three phases follow: Prehabilitation, training and follow-up. The sample will be constituted by 60 candidates for LT, randomized in a control group (CG, n=20), a Prehabilitation group (PG, n=20) and a Prehabilitation-posttransplant training group (PTG, n=20). To conventional care, a Prehabilitation program will be added to the PG and PTG. After the LT, just PTG will follow a posttransplant training program. The long-term follow-up will be extended to 2 years post-LT. The variables under study will be: complications and post-S evolution; FC; quality of life; etc. The individualization of Prehabilitation and posttransplant training program, and also medical control, will ensure safety and offer the potential benefits that these types of programs can provide.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Indication of elective liver transplant with favorable cardiorespiratory evaluation that does not contraindicate the transplant.

Exclusion criteria

  • Any orthopedic, motor, functional, neurological, cognitive or linguistic limitation that prevents the realization of the Prehabilitation program
  • Inability to perform psychometric tests
  • Esophageal varices not treated with ligature or beta-blockers
  • Varicose veins with a high risk of digestive hemorrhage
  • Hemoglobin <80 g/l
  • Contraindication to weight loading
  • Impossibility to comply with the Prehabilitation program (hospital admission, work, geographical location)
  • Multi-organ transplantation and liver retransplantation
  • Refusal or lacks capacity to give informed consent

Treatment and study plan

Prehabilitation

Other

Supervised training program of 8-weeks and a frequency of 2 days/week. It includes interval aerobic exercise (5 cycles of 2 minutes at 70 percentage of Watts or heart rate of cardiopulmonary exercise testing (CEPT) and 3 minutes of active rest at 40 percentage; peripheral muscle training and balance exercises in a circuit of 10 phases, 10 to 15 repetitions, from 1 to 3 sets (the participants will work at moderate intensity, no more than 5-6/10 on the modified Borg scale); Inspiratory Muscle Training (IMT) through a threshold loading device [2 sessions / day, 3 sets of 15 repetitions, at 60-70 percentage of the maximum inspiratory pressure (cmH2O)]; ventilatory reeducation by an incentive inspirator based on the vital capacity evaluated in the initial spirometry. Both the aerobic modality and the resistance training, will increase the intensity of work (HR, Watts, Kg or cmH2O) between 2-5 percentage every 2 weeks complying with the principle of training overload.

Other names: Interval aerobic exercise, peripheral and respiratory muscle training, balance exercise

Prehabilitation and posttransplant training program

Other

Prehabilitation will be followed by a posttransplant training program. In this, the patient will perform supervised exercise (IIa interval aerobic exercise and resistance training) 2 days / week, and a physical exercise program at home until completing a total of 5 sessions / week in the aerobic modality. In the unsupervised phase (IIb), the patient will continue with the learned physical exercise program, but without supervision, 5 sessions / week (including a minimum of 2 non-consecutive sessions to perform resistance training).

Other names: Interval aerobic exercise, peripheral muscle training and balance exercise

Primary outcomes

  1. Morbidity

    Time frame: The groups will be assessed from the hospitalization up to 24-months.

    Registry of post-surgical complications according to the Clavien-Dindo classification. Reference: Ann Surg 2004; 240(2):205-13.

  2. Mortality

    Time frame: The groups will be assessed from the hospitalization until the date of death, assessed up to 24-months.

    Registry of mortality

  3. Number of hospitalization days

    Time frame: The groups will be assessed during hospitalization, approximately 7 days.

    Registry of number of days of hospitalization in intensive care unit and ward.

  4. Number of days with supplementary oxygen therapy and/or mechanical ventilation

    Time frame: The groups will be assessed during hospitalization, approximately 7 days.

    Registry of number of days

  5. Progression in the activities of daily life (ADL)

    Time frame: The groups will be assessed during hospitalization, approximately 7 days.

    Days of acquisition, sitting, walking and stairs

Secondary outcomes

  1. Change in functional capacity: measurement of oxygen uptake

    Time frame: The groups will be assessed at four times: at baseline; at week 8; 3-months after LT; and 6-months after LT.

    Cardiopulmonary exercise test following an incremental protocol on ramp with a bicycle ergometer.

  2. Change in functional capacity: 6-minutes walking test (6MWT)

    Time frame: The groups will be assessed at four times: at baseline; at week 8; 3-months after LT; and 6-months after LT.

    6MWT is a submaximal exercise test that entails measurement of distance walked over a span of 6 minutes. The 6 MWT provides information regarding functional capacity, response to therapy and prognosis. American Thoracic Society (ATS) Statement Guidelines for the Six-Minute Walk Test. Am J Resp Crit Care Med 2002;166(1):111-117

  3. Change in peripheral muscle strength: handgrip strength, quadriceps femoris strength and biceps brachii strength

    Time frame: The groups will be assessed at six times: at baseline; at week 8; 1-month, 3-months, 6-months and 24-months after LT.

    Isometric peripheral muscle strength will be measured using a digital hand dynamometer and the unit of measure is kilograms. References:

    Roberts HC, Denison HJ, Martin HJ, Patel HP, Syddall CC, Sayer AA. A review of the measurement of grip strength in clinical and epidemiological studies: towards a standardised approach. Age and Ageing 2011;40(4):423-9.

    Andrews AW, Thomas MW, Bohannon RW. Normative values for isometric muscle force measurements obtained with hand-held dynamometers. Phys Ther. 1996; 76(3):248-59

  4. Change in respiratory strength: maximum inspiratory pressure (MIP) and maximum expiratory pressure (MEP)

    Time frame: The groups will be assessed at baseline and at week 8.

    Maximum respiratory pressures will be measured using a Respiratory Pressure Meter MicroRPM® and the unit of measure is cmH2O. MIP and MEP are probably the most frequently reported non-invasive estimates of respiratory muscle strength. Ever since Black and Hyatt (1969) reported this technique it has been widely used in patients, healthy control subjects across all ages, and athletes. Pressure is recorded at the mouth during a quasi-static short (few seconds) maximal breathing. Reference: Am J Respir Crit Care Med. 2002;166:531-535

  5. Change in performance on the Short Physical Performance Battery (SPPB)

    Time frame: The groups will be assessed at six times: at baseline; at week 8; 1-month, 3-months, 6-months and 24-months after LT.

    The SPPB is a simple test to measure lower extremity function using tasks that mimic daily activities. The SPPB examines three areas of lower extremity function; static balance, gait speed, and getting in and out of a chair. Static balance is measured in units of time (seconds) and patients are timed holding 3 different stances. Gait speed is measured in time (seconds) to walk 4 meters. Chair sits are measured as the time (seconds) it takes to get up and out of a chair 5 times without using one's arms to assist the exercise. Collectively, the three tests are used to generate a total score (0-12) that reflects a patient's frailty (score of 0) or lack of frailty (score of 12). Guralnik JM, Simonsick EM, Ferrucci L, Glynn RJ, Berkman LF, Blazer DG, Scherr PA, Wallace RB. A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol. 1994;49:M85-M94.

  6. Change in muscle mass

    Time frame: The groups will be assessed at six times: at baseline; at week 8; 1-month, 3-months, 6-months and 24-months after LT.

    Bioelectrical impedance analysis will be completed using the Bodystat 1500 MDD, which is a multi-frequency body composition analyzer. Body fat percentage (%) will be compared to lean body mass percentage and total body water percentage to assess sarcopenia and nutritional status.

  7. Change in Quality of life

    Time frame: The groups will be assessed at six times: at baseline; at week 8; 1-month, 3-months, 6-months and 24-months after LT.

    Short-Form Liver Disease Quality of Life (SF-LDQOL) is formed by 9 dimensions: symptoms of the disease, effects of the disease on the activities of daily life, memory/concentration, anxiety, sleep, loneliness, hopelessness, stigma for the disease and sexual functioning. The minimum and maximum values of the scale are 0-100, so that the higher the score, the better health related quality of life (HRQL).

Sponsors and collaborators

Lead sponsor

Maria dels Angels Cebria i Iranzo, PT, PhD

Other

Collaborators

  • University of Valencia

Registry information

Official study title

Effects of a Prehabilitation Program in Liver Transplant Candidates Followed by a Posttransplant Training Program

Acronym: PreLiveR-T

Important dates

Study start
2021
Primary completion
2026
Study completion
2026
First posted
Jan 29, 2020
Registry last updated
Sep 15, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.